LANREOTIDE

lanreotide 90 mg/0.5 mL injection, 0.5 mL syringe

LANREOTIDE (15636Y)

lanreotide 90 mg/0.5 mL injection, 0.5 mL syringe
15636Y
Body System:
Manner of administration:Injection
S100 HSD Community Access
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19548)

Indication: Functional carcinoid tumour
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $2,402.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Mytolac
Somatuline Autogel